Bitter Pills:Medicines & The Third World Poor | Page 222

pharmaceutical specialities. Against the supply of these items, we purchase from Bangladesh goods such as molasses, textiles, industrial gloves, wheat grain for animal feed, jute and jute goods, wet blue skin, tea, cutlery, for none of which it is easy to find a ready buyer. We can even claim that we provide aid to Bangladesh through our contacts with customers for these goods by supplying know-how to that country, for example in the manufacture of textiles and for the production of cutlery. We feel this should be mentioned in order to complete the picture of our activities in the country ..." (Drs. Mehrhof and Niederehe, E. Merck, personal communication, 29 March 1982.) But the former Director of Drug Administration questions how much the barter arrangement is really helping Bangladesh in exchanging mainly finished medicines (many of which are "non-essential") for commodities (like jute, jute goods, tea and hides) which are 'easily exportable items, and if sold in the open international market would fetch valuable hard foreign exchange." "The statement that import of E. Merck products does not cost us a penny in foreign exchange is mischievous." (Dr. H.K.M.A. Hye, personal communication, 20 April 1982.) 92 Government of the People's Republic of Bangladesh, "Import Figures of Pharmaceuticals Raw Materials for the calendar year 1980". 93 Hye, 10 August 1981, op. cit. 94 Expert Committee, Bangladesh, op. cit., p.92. 95 Ibid. 96 Pascale Brudon, "L'lndustrie Pharmaceutique Suisse dans les Pays sous developpes", Memoire presente pour le diplome de recherche en etudes de developpement, Institut Universitaire d'Etudes de Developpement, Geneva, 1981. Of the 36:13 are for psychiatric and neurological use; 7 cardiovasculars; 3 antibiotics; 2 anti-cancer drugs, (p.211) 97 Ibid. 98 Ibid., p.202. 99 Ibid., p.203. Sandoz has a similar vanilla-flavoured preparation Meritene amongst its bestselling products in Mexico (p.207). 100 Ibid., p.257. 101 See Chapter 10. 102 Information Research Limited, "Opportunities for Pharmaceuticals in the Developing world over the next Twenty Years", June 1980, p.7. CHAPTER 4 1 Dr. &